The invention relates to compounds of general formula I:
wherein R1, R2 and R3 are as defined in the description such compounds are metabotropic glutamate receptor antagonists and are useful in the treatment or prevention of mGluR5 receptor mediated disorders.
本发明涉及一般式I的化合物:其中R1,R2和R3如说明书中所定义,这些化合物是代谢型谷
氨酸受体拮抗剂,可用于治疗或预防mGluR5受体介导的疾病。